Category Archives: Patents

The Week (so far) in med tech

April is not yet complete, but two items of interest already bear noting. One of these is perhaps the most important patent case to be heard by the Supreme Court in a long time, at least where life sciences are…

FacebookTwitterGoogle+Share

Myriad, Prometheus and life science patents: The End of Days?

The Supreme Court decision in Mayo v. Prometheus and the Court’s remand of Myriad have provoked a lot of angst on the part of those in the life sciences. Still, the degree to which these cases might prove cataclysmic is…

FacebookTwitterGoogle+Share

Patent reform in search of respect

We who scribble for a living find it easy to go off on those who do not, and today’s bulls-eye is on the patent reform bill recently signed into law, the America Invents Act of 2011. One of the interesting…

FacebookTwitterGoogle+Share

The law of unintended consequences

  The title of this posting pretty much says it all, but I’m paid to tap out words on my keyboard. So here we go. Remember FDA’s draft guidance on when to file a 510(k)? Among the things it stipulates…

FacebookTwitterGoogle+Share

Top Five Things to Watch for in 2011

In the world of diagnostic and therapeutic devices, 2011 has already been a busy year, but a third of the year remains. There are still numerous developments that will trigger cheer and jeers, depending on where you sit. This is…

FacebookTwitterGoogle+Share

Fee diversion alive and well in H.R. 1249

Those with a keen eye trained on the patent reform bill now under consideration in the House of Representatives might universally hold a dim view of fee diversion even if they see first-to-file and the prior user defense through profoundly…

FacebookTwitterGoogle+Share

Patent reform: All aboard, the train has left the station

The U.S. House of Representatives is expecting a vote this week on its patent reform bill, but unlike passage of the Senate bill, the House bill has to deal with a potentially crippling conflict. This conflict was set up by…

FacebookTwitterGoogle+Share

Doc fix awaiting another patch

Now that the U.S. House of Representatives has voted down a higher debt ceiling for the U.S. government, Congress can go back the drawing board on deciding how many Medicare spending cuts the voters and stakeholders can stomach, but as…

FacebookTwitterGoogle+Share

Quoth the [Patent Reform] Maven; Nevermore?

(For those who wonder whether Congress will ever pass a patent reform bill, we offer the following with a tip o’ the hat to Edgar Allan Poe….) Once upon a mid-day dreary, While I pondered dazed and bleary, O’er forgotten…

FacebookTwitterGoogle+Share

First-to-file vs. first-to-invent: Which patent system would be better for the U.S.?

Patent reform legislation has been in the news quite a bit the past few weeks in the U.S., with both chambers of Congress working on legislation that could affect the way patents are currently registered. The U.S. patent system is…

FacebookTwitterGoogle+Share

Marketo